Health Condition 1: C61- Malignant neoplasm of prostate
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Adult Patient (age in completed years above 18) 2) PSA >5 ng/ml 3) Positive Digital rectal examination
Exclusion criteria
Exclusion criteria: 1) Histopathology other than adenocarcinoma. 2) MRI contraindications like pacemakers. 3) Contraindications for contrast administration like previous h/o reaction to Gadolinium, deranged renal function tests, etc. 4) Poor general condition/ performance status (e.g.- acute heart failure etc.) 5) Non consenting patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prostate cancer detection rate comparison for MRI ingantry targeted biopsy and MRI-TRUS fusion targeted biopsies and CEUS-guided targeted biopsies compared with 12-core systematic biopsiesTimepoint: Cancer detection rate by biopsy within 1 week of MRI | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the value of using both mpMRI and CEUS in the detection of prostate cancer To study feasibility of IVIM in the detection of prostate cancerTimepoint: 6 weeks post biopsy (if biopsy already done) | — |
Countries
India
Contacts
AIIMS, New Delhi